Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Mizel currently holds 445,708 shares of PACIFICHEALTH LABORATORIES INC (PHLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Mizel has been a net buyer of PHLI stock. They have purchased $142.9K and sold $59.6K worth of shares.
Adam Mizel's most recent insider trade was on Mar 21, 2013, when they sold 100,000 shares at $0.00 per share.
Adam Mizel serves as Executive at PACIFICHEALTH LABORATORIES INC (PHLI). They have executed 33 insider transactions totaling $202.5K over their tenure at the company.
Adam Mizel holds the position of Executive at PACIFICHEALTH LABORATORIES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Adam Mizel has shown a buying trading pattern, with $142.9K in total purchases and $59.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Adam Mizel was on Nov 28, 2012, when they sold $59.6K worth of CIDM shares. This transaction involved 37,721 shares at $1.58 per share.
Adam Mizel currently owns 445,708 shares of PACIFICHEALTH LABORATORIES INC (PHLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Mizel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Mizel has 33 Form 4 filings on record as an insider at PACIFICHEALTH LABORATORIES INC.
Set alerts for Adam Mizel and 40,000+ other insiders.